Study Comparing Blood Pressure Treatment Based on Office Measurements
Versus 24-Hour Ambulatory Monitoring in Adults with Masked Hypertension
Led by Istituto Auxologico Italiano · Updated on 2026-03-30
1240
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating management strategies for masked uncontrolled hypertension to see if using out-of-office blood pressure BP monitoring improves health outcomes compared to office BP measurements. This 4-year, prospective, randomized, open-label, blinded-endpoint study PROBE aims to compare cardiovascular and kidney-related results between these two approaches. The study will recruit 1240 adults aged 35 to 80 years and is sponsored by Istituto Auxologico Italiano.
Participants are randomly assigned to one of two groups one using office BP to guide antihypertensive treatment and the other using 24-hour ambulatory BP monitoring ABPM to guide treatment. The study includes a 12-month period focusing on changes in left ventricular mass index LVMI and urinary albumin excretion UAE, with follow-up continuing for a total of 48 months to observe cardiovascular events, mortality, and other health changes.
During the study, participants will have their BP management optimized according to their assigned group. Researchers will assess blood pressure-related variables, LVMI, and UAE at one year and monitor cardiovascular and cerebral events through the full 4 years. The study measures these co-primary endpoints at 12 months and collects outcome data on mortality and morbidity over 48 months, ensuring thorough evaluation of each management strategys effects.
CONDITIONS
Brief Title
MASked-unconTrolled hypERtension Management Based on Office BP or on Out-of-office (Ambulatory) BP Measurement
Research Team
G
Gianfranco Parati, MD
A
Alberto Zanchetti, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Diagnosed with masked uncontrolled hypertension: office BP below 140/90 mmHg plus one or more of these ambulatory BP criteria: daytime BP over 135/85 mmHg, night-time BP over 120/70 mmHg, or 24-hour BP over 130/80 mmHg
Estimated glomerular filtration rate (eGFR) 45 mL/min/1.73 m2 or higher
You will not qualify if you...
Estimated glomerular filtration rate (eGFR) below 45 mL/min/1.73 m2 or severe chronic kidney failure
Unstable clinical conditions
Known secondary hypertension
Orthostatic hypotension with systolic BP drop over 20 mmHg on standing
Clinical diagnosis of dementia
Liver disease with AST or ALT levels more than twice normal
History of gastrointestinal surgery or disorders affecting drug absorption
Allergy or contraindications to study drugs
History of cancer (excluding basal cell skin cancer) within the last 5 years
Clinically significant autoimmune disorders like systemic lupus erythematosus
History of drug or alcohol abuse within the last 5 years
History of non-compliance with medical treatments or considered unreliable
Inability or unwillingness to give informed consent
Pregnancy or planning pregnancy during the study period
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - 12 months
Participants receive optimization of antihypertensive treatment based on either office blood pressure or 24-hour ambulatory blood pressure monitoring as a guide.
Regular visits scheduled during the 12 months of treatment
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol.
Gianfranco Parati, Enrico Agabiti-Rosei, George L Bakris...